Indivior Share Price | |
---|---|
Price | 1,357.00 |
Bid | 1,343.00 |
Ask | 1,347.00 |
Change | 29.00 (2.18%) |
Volume | 1,086,886 |
Open | 1,331.00 |
High | 1,358.00 |
Low | 1,299.00 |
Prev. Close | 1,328.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 134.89m |
Market Capitalisation | £1.83b |
Market Size | 500 |
52 Week High | 1,927.00 |
52 Week High Date | 27-Jul-2023 |
52 Week Low | 1,128.00 |
52 Week Low Date | 19-Dec-2023 |
# Trades | 1,202 |
---|---|
Vol. Sold | 66,756 |
Sold Value | £891.29k |
Vol. Bought | 283,516 |
Bought Value | £3.82m |
PE Ratio | 1,727.72483 |
Earnings | 0.785426 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
24-May-24 | 14:30:27 | 1,331.00 | 368,000 | Unknown* | 1,343.00 | 1,347.00 | 5m | O Ordinary Delayed publication Was reported as OTC |
24-May-24 | 14:31:28 | 1,331.00 | 368,000 | Unknown* | 1,343.00 | 1,347.00 | 5m | O Ordinary Delayed publication Was reported as OTC |
24-May-24 | 16:47:00 | 1,345.835 | 15,000 | Buy* | 1,343.00 | 1,347.00 | 201.88k | O Ordinary |
24-May-24 | 16:35:22 | 1,357.00 | 150,534 | Buy* | 1,343.00 | 1,347.00 | 2m | UT Uncrossing Trade |
24-May-24 | 16:29:25 | 1,346.00 | 58 | Buy* | 1,344.00 | 1,346.00 | 780.68 | A Automatic Execution |
24-May-24 | 16:28:50 | 1,345.00 | 49 | Sell* | 1,344.00 | 1,347.00 | 659.05 | O Ordinary Trade was executed as an SI |
24-May-24 | 16:28:16 | 1,346.00 | 149 | Buy* | 1,344.00 | 1,346.00 | 2,006 | O Ordinary Trade was executed as an SI |
24-May-24 | 16:26:01 | 1,345.00 | 48 | Sell* | 1,345.00 | 1,347.00 | 645.60 | A Automatic Execution |
24-May-24 | 16:25:23 | 1,345.00 | 42 | Sell* | 1,345.00 | 1,347.00 | 564.90 | A Automatic Execution |
24-May-24 | 16:24:55 | 1,345.00 | 75 | Buy* | 1,344.00 | 1,345.00 | 1,009 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
14-May-24 | 09-May-24 | Buy | Mark Stejbach held the position of Independent Non-Executive Director at the time of this trade.Mark Stejbach | 17.98 | USD | 550 | 13,134 |
18-Mar-24 | 15-Mar-24 | Transfer From | Ryan Preblick held the position of CFO & Executive Director at the time of this trade.Ryan Preblick | 0.00 | 3,920 | 229,089 | |
18-Mar-24 | 18-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,617.00 | GBX | 10,549 | 335,935 |
18-Mar-24 | 15-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,644.00 | GBX | 15,444 | 335,935 |
18-Mar-24 | 14-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,630.00 | GBX | 91,204 | 335,935 |
Indivior is working to change patients lives by developing medicines to treat addiction and serious mental illnesses.